US 7582765
Aryl aniline β2 adrenergic receptor agonists
granted A61KA61K31/136A61K31/277
Quick answer
US patent 7582765 (Aryl aniline β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/136, A61K31/277, A61K31/325, A61K31/33